Received May 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
Pain; Itching; burning; Redness; This non-serious case was reported by a physician via call center representative and described the occurrence of pain in a male patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included herpes zoster (The patient had reported an episode of zoster before receiving the Shingrix doses). Concomitant products included VARICELLA ZOSTER VACCINE RGE (CHO) (SHINGRIX). In MAR-2021, the patient received the 2nd dose of Shingrix. In MAY-2025, more than 2 years after receiving Shingrix, the patient experienced pain (Verbatim: Pain), pruritus (Verbatim: Itching), burning sensation skin (Verbatim: burning) and erythema (Verbatim: Redness). The patient was treated with triamcinolone. The outcome of the pain, pruritus, burning sensation skin and erythema were unknown. It was unknown if the reporter considered the pain, pruritus, burning sensation skin and erythema to be related to Shingrix. It was unknown if the company considered the pain, pruritus, burning sensation skin and erythema to be related to Shingrix. Additional Information: GSK Receipt Date: 23-MAY-2025 The reporter, an HCP (physician), stated that he had received two doses of Shingrix, his initial dose in December 2020 and his second in March 2021. The previous night, he had developed pain, redness, itching, and burning on the left side of his upper abdomen, which was about 4 inches wide. He had applied triamcinolone to the area. He did not know if it was shingles. The patient had reported an episode of zoster before receiving the Shingrix doses.
Medical History/Concurrent Conditions: Herpes zoster (The patient had reported an episode of zoster before receiving the Shingrix doses)
SHINGRIX